This inventor holds 1 USPTO granted patent. Top assignee: North Carolina State University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Jan-Peter Van Pijkeren: Innovator in CRISPR Technology
Introduction
Jan-Peter Van Pijkeren is a prominent inventor based in Madison, WI (US). He has made significant contributions to the field of biotechnology, particularly in the development of antimicrobial solutions using CRISPR technology. His innovative work focuses on enhancing the delivery of CRISPR-based antimicrobials, which has the potential to revolutionize how we combat bacterial infections.
Latest Patents
Jan-Peter Van Pijkeren holds a patent for "Methods and compositions for delivery of CRISPR based antimicrobials." This invention is directed to antibacterial compositions comprising bacteria modified to include phasmids engineered to deliver CRISPR RNAs. The methods outlined in this patent provide a novel approach to utilizing CRISPR technology for antimicrobial purposes, showcasing his expertise in genetic engineering and microbiology. He has 1 patent to his name.
Career Highlights
Van Pijkeren is affiliated with North Carolina State University, where he continues to advance research in microbial genetics and CRISPR applications. His academic background and research initiatives have positioned him as a leader in the field, contributing to both scientific knowledge and practical applications in healthcare.
Collaborations
One of his notable collaborators is Rodolphe Barrangou, a fellow researcher who shares a commitment to exploring the potential of CRISPR technology. Their partnership exemplifies the collaborative spirit of scientific research, driving innovation and discovery in the field.
Conclusion
Jan-Peter Van Pijkeren's work in CRISPR technology represents a significant advancement in the fight against bacterial infections. His innovative approaches and dedication to research continue to inspire future developments in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
